Monica M. Jablonski, Ph.D.

Monica M. Jablonski, Ph.D.

Professor
Department of Ophthalmology
Department of Anatomy and Neurobiology


The University of Tennessee Health Science Center
Hamilton Eye Institute
930 Madison Avenue, Suite 710
Memphis, TN 38163
Phone: (901) 448-7572
Fax: (901) 448-5028
Email: Monica M. Jablonski



Education

  • Ph.D. Institution: Medical College of Wisconsin, Department of Physiology
  • Postdoctoral: Baylor College of Medicine, Department of Ophthalmology

Link

Research Interests

Mechanisms that regulate photoreceptor outer segment assembly; mouse models of eye disease; proteomics; retinal cell biology; mutagenesis; genetics modulators of glaucoma

Representative Publications

  • Chekuri A, Sahu B, Chavali VRM, Voronchikhina M, Hermida AS, Suk JJ, Alapati AN, Bartsch DU, Ayala-Ramirez R, Zenteno JC, Dinculescu A, Jablonski MM, Borooah S, Ayyagari R. The long-term effects of gene therapy in a novel mouse model of human MFRP-associated retinopathy. Hum Gene Ther. 2018 Nov 30. doi: 10.1089/hum.2018.192. [Epub ahead of print] PubMed PMID: 30499344.
  • Cui J, Li J, Lu H, Yu H, Wei D, Jiao Y, Jablonski MM, Gu W, Chen H. Data sets of eQTL loci, correlation analysis, and overlapped genes among gene sets that their expression levels are closely related to genes of Vegf family. Data Brief. 2018 Sep 8;20:1854-1860. doi: 10.1016/j.dib.2018.09.004. eCollection 2018 Oct. PubMed PMID: 30294635; PubMed Central PMCID: PMC6169370.
  • Cui J, Liu L, Lu H, Wei D, Jiao Y, Jablonski MM, Williams RW, Gu W, Chen H. Potential effect on molecular pathways in different targeted genes in the VEGF family in retina - From the genomic point of view. Exp Eye Res. 2018 Nov;176:78-87. doi: 10.1016/j.exer.2018.06.024. Epub 2018 Jun 23. PubMed PMID: 29944851.
  • Janga KY, Tatke A, Shukla S, Lamichhane SP, Avula B, Wang X, Jablonski MM, Khan IA, Majumdar S. Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide. J Pharm Sci. 2018 Aug;107(8):2128-2135. doi: 10.1016/j.xphs.2018.04.008. Epub 2018 Apr 17. PubMed PMID: 29678592.
  • Tatke A, Janga KY, Avula B, Wang X, Jablonski MM, Khan IA, Majumdar S. P-glycoprotein Restricts Ocular Penetration of Loperamide across the Blood-Ocular Barriers: a Comparative Study in Mdr1a Knock-out and Wild Type Sprague Dawley Rats. AAPS PharmSciTech. 2018 May;19(4):1662-1671. doi: 10.1208/s12249-018-0979-2. Epub 2018 Mar 8. PubMed PMID: 29520587.
  • Janga KY, Tatke A, Balguri SP, Lamichanne SP, Ibrahim MM, Maria DN, Jablonski MM, Majumdar S. Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation. Artif Cells Nanomed Biotechnol. 2018 Feb 23:1-12. doi: 10.1080/21691401.2018.1443117. [Epub ahead of print] PubMed PMID: 29475386; PubMed Central PMCID: PMC6148389.

View more references (pubmed link)